+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Immuno Oncology Assays Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno Oncology Assays Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 185 Pages
  • Global
From
Immuno-oncology Clinical Trials Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-oncology Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Oral Cancer Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oral Cancer Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Head & Neck Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Head & Neck Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Cancer Biological Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Biological Therapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Oncology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Gastric Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Gastric Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Urothelial Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Urothelial Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Immunotherapy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Antineoplastic Agents Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antineoplastic Agents Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 185 Pages
  • Global
From
Throat Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Throat Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 267 Pages
  • Global
From
Oral Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 182 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Oncolytic Virotherapy - Global Strategic Business Report 2026 - Product Thumbnail Image

Oncolytic Virotherapy - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 243 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 377 Pages
  • Global
From
From
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more